Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae In Vitro or Suppress Emergence of Ceftazidime-Avibactam Resistance

Por Shields, Ryan K., Nguyen, M. Hong, Hao, Binghua, Kline, Ellen G., Clancy, Cornelius J.
Publicado no Antimicrob Agents Chemother (2018)

1580. Colistin Potentiates the In Vitro Activity of Meropenem–Vaborbactam (M/V) Against Some, but not All KPC-producing Klebsiella pneumoniae (KPC-Kp)

Por Jones, Chelsea E, Kline, Ellen G, Nguyen, Minh-Hong, Clancy, Cornelius J, Shields, Ryan K
Publicado no Open Forum Infect Dis (2019)

710. In Vitro Activity and Performance of Available Susceptibility Testing Methods for Eravacycline Against Carbapenem-Resistant Enterobacteriaceae (CRE)

Por Jones, Chelsea E, Kline, Ellen G, Nguyen, Minh-Hong, Clancy, Cornelius J, Shields, Ryan K
Publicado no Open Forum Infect Dis (2019)

Spontaneous Mutational Frequency and FKS Mutation Rates Vary by Echinocandin Agent against Candida glabrata

Por Shields, Ryan K., Kline, Ellen G., Healey, Kelley R., Kordalewska, Milena, Perlin, David S., Nguyen, M. Hong, Clancy, Cornelius J.
Publicado no Antimicrob Agents Chemother (2018)

Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae

Por Wilson, William R., Kline, Ellen G., Jones, Chelsea E., Morder, Kristin T., Mettus, Roberta T., Doi, Yohei, Nguyen, M. Hong, Clancy, Cornelius J., Shields, Ryan K.
Publicado no Antimicrob Agents Chemother (2019)

2247. Real-world Experience with Meropenem–Vaborbactam (M/V) for Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections

Por Shields, Ryan K, McCreary, Erin K, Marini, Rachel V, Kline, Ellen G, Jones, Chelsea E, Hao, Binghua, Clancy, Cornelius J, Nguyen, Minh-Hong
Publicado no Open Forum Infect Dis (2019)